Brief: Zoetis To Acquire Animal Genomics Business From Neogen®, Accelerating Precision Animal Health Innovation
02/03/2026 13:58
March 2 (Reuters) - Neogen Corp NEOG.O: ZOETIS TO ACQUIRE ANIMAL GENOMICS BUSINESS FROM NEOGEN®, ACCELERATING PRECISION ANIMAL HEALTH INNOVATION ZOETIS INC - TO BUY NEOGEN'S ANIMAL GENOMICS BUSINESS FOR $160 MILLION Source text: ID:nBw9f87hQa Further company coverage: NEOG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies